• LAST PRICE
    38.0600
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    27.6500/ 1
  • Ask / Lots
    49.0000/ 1
  • Open / Previous Close
    0.0000 / 38.0600
  • Day Range
    ---
  • 52 Week Range
    Low 12.7500
    High 67.2100
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 40.61
TimeVolumePRAX
09:32 ET258539.89
09:34 ET181840.095
09:36 ET4167640.23
09:38 ET224040.015
09:39 ET1954939.36
09:41 ET2521839.36
09:43 ET4943539.41
09:45 ET1646839
09:48 ET143239.56
09:50 ET1227739.675
09:52 ET1167538.78
09:54 ET10039.61
09:56 ET107639.58
09:57 ET91239.59
09:59 ET155539.34
10:03 ET10039.3
10:06 ET20039.225
10:08 ET10039.365
10:10 ET20039.62
10:26 ET40039.875
10:28 ET10039.675
10:30 ET105739.455
10:33 ET17146639.63
10:35 ET25039.59
10:37 ET19039.58
10:39 ET31239.27
10:42 ET1044938.75
10:44 ET274439.36
10:46 ET20039.23
10:50 ET83739.01
10:53 ET68738.885
10:55 ET85939.05
11:00 ET60039.31
11:02 ET15339.17
11:04 ET62539
11:09 ET10039.27
11:13 ET10039.145
11:15 ET10039.1564
11:18 ET10039.03
11:20 ET14439
11:22 ET90039.01
11:24 ET10038.98
11:27 ET129739.14
11:29 ET10039.14
11:33 ET10039.14
11:36 ET221139.16
11:38 ET40038.99
11:40 ET10038.99
11:44 ET30039.05
11:45 ET10038.985
11:51 ET50038.985
11:54 ET110039.09
11:56 ET70039.015
11:58 ET10039.01
12:02 ET10038.94
12:03 ET30038.93
12:05 ET50038.97
12:07 ET10038.93
12:09 ET10039
12:12 ET70139.04
12:14 ET60539.13
12:16 ET10039.13
12:18 ET20039.125
12:20 ET10039.17
12:21 ET30039.28
12:23 ET10039.4499
12:25 ET60039.24
12:27 ET10039.24
12:32 ET50039.15
12:34 ET50039.065
12:41 ET50039.105
12:43 ET20039.055
12:48 ET10039
12:52 ET10039.025
12:57 ET272139.18
12:59 ET202039.38
01:03 ET150039.28
01:08 ET20039.23
01:10 ET70039.1
01:12 ET280039.06
01:14 ET286738.92
01:15 ET50039
01:17 ET90539.14
01:19 ET20039.085
01:21 ET30039.24
01:24 ET30039.26
01:26 ET98139.3
01:33 ET10039.23
01:35 ET10039.16
01:44 ET10039.15
01:46 ET70039.075
01:48 ET100039.2
01:53 ET30039.1
01:55 ET10039.06
01:57 ET20038.97
02:00 ET20039.03
02:02 ET30038.98
02:04 ET20039
02:08 ET356038.85
02:09 ET250038.875
02:11 ET300638.9
02:13 ET100038.89
02:15 ET30038.89
02:18 ET20038.84
02:20 ET70639
02:22 ET1030038.935
02:24 ET388338.805
02:26 ET737938.57
02:27 ET90038.26
02:29 ET310038.32
02:31 ET117837.95
02:33 ET100037.855
02:36 ET285037.89
02:38 ET20037.89
02:40 ET24837.88
02:42 ET60037.69
02:44 ET10037.7
02:45 ET367037.65
02:47 ET201337.5
02:49 ET90037.2
02:51 ET260037.13
02:54 ET190037.33
02:56 ET351837.55
02:58 ET50037.5
03:00 ET157637.47
03:02 ET460037.395
03:03 ET251737.54
03:05 ET69737.6
03:07 ET40937.525
03:09 ET43737.535
03:12 ET50237.525
03:14 ET350037.675
03:16 ET134137.91
03:18 ET150037.79
03:20 ET80037.695
03:21 ET1196137.895
03:23 ET90237.98
03:25 ET255638.14
03:27 ET111237.915
03:30 ET289938.09
03:32 ET849638.3
03:34 ET102438.335
03:36 ET90038.16
03:38 ET287638.215
03:39 ET336038.15
03:41 ET90037.995
03:43 ET2165238.04
03:45 ET822038.195
03:48 ET221138.31
03:50 ET120038.2299
03:52 ET170038.1799
03:54 ET567838.275
03:56 ET1529538.09
03:57 ET1002738.26
03:59 ET1108838.06
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRAX
Praxis Precision Medicines Inc
651.1M
-2.4x
---
United StatesCATX
Perspective Therapeutics Inc
643.5M
-5.9x
---
United StatesHLVX
Hillevax Inc
649.9M
-4.0x
---
United StatesOLMA
Olema Pharmaceuticals Inc
656.1M
-5.8x
---
United StatesSRRK
Scholar Rock Holding Corp
643.6M
-3.9x
---
United StatesPROK
ProKidney Corp
631.4M
-3.9x
---
As of 2024-06-26

Company Information

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, is an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include ulixacaltamide, PRAX-562, PRAX-628 and elsunersen.

Contact Information

Headquarters
99 High Street, 30th FloorBOSTON, MA, United States 02110
Phone
617-300-8460
Fax
302-655-5049

Executives

Independent Chairman of the Board
Dean Mitchell
President, Chief Executive Officer, Director
Marcio Souza
Chief Financial Officer
Timothy Kelly
Vice President - Legal
Alex Nemiroff
Independent Director
Jeffrey Chodakewitz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$651.1M
Revenue (TTM)
$2.2M
Shares Outstanding
17.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.74
EPS
$-15.91
Book Value
$7.92
P/E Ratio
-2.4x
Price/Sales (TTM)
296.6
Price/Cash Flow (TTM)
---
Operating Margin
-5,930.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.